TelyRx Holdings Statistics

Total Valuation

TelyRx Holdings has a market cap or net worth of CAD 136.19 million. The enterprise value is 148.37 million.

Market Cap	136.19M
Enterprise Value	148.37M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TelyRx Holdings has 46.96 million shares outstanding.

Current Share Class	24.47M
Shares Outstanding	46.96M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	8.89%
Owned by Institutions (%)	n/a
Float	24.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.31
PB Ratio	-11.72
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.95
EV / Sales	2.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-79.74

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-8.75
Interest Coverage	-7.21

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-33.41%
Return on Invested Capital (ROIC)	-60.26%
Return on Capital Employed (ROCE)	80.13%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	4.82
Inventory Turnover	21.64

Taxes

In the past 12 months, TelyRx Holdings has paid 24,680 in taxes.

Income Tax	24,680
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.65
Average Volume (20 Days)	6,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TelyRx Holdings had revenue of CAD 58.85 million and -7.44 million in losses. Loss per share was -0.70.

Revenue	58.85M
Gross Profit	31.97M
Operating Income	-6.53M
Pretax Income	-7.41M
Net Income	-7.44M
EBITDA	-6.40M
EBIT	-6.53M
Loss Per Share	-0.70

Full Income Statement

Balance Sheet

The company has 4.10 million in cash and 16.27 million in debt, with a net cash position of -12.17 million or -0.26 per share.

Cash & Cash Equivalents	4.10M
Total Debt	16.27M
Net Cash	-12.17M
Net Cash Per Share	-0.26
Equity (Book Value)	-11.62M
Book Value Per Share	-1.09
Working Capital	-14.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.06 million and capital expenditures -804,847, giving a free cash flow of -1.86 million.

Operating Cash Flow	-1.06M
Capital Expenditures	-804,847
Depreciation & Amortization	134,274
Net Borrowing	2.59M
Free Cash Flow	-1.86M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 54.32%, with operating and profit margins of -11.10% and -12.64%.

Gross Margin	54.32%
Operating Margin	-11.10%
Pretax Margin	-12.60%
Profit Margin	-12.64%
EBITDA Margin	-10.87%
EBIT Margin	-11.10%
FCF Margin	n/a

Dividends & Yields

TelyRx Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.46%
FCF Yield	-1.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 7, 2026. It was a reverse split with a ratio of 0.0333333.

Last Split Date	Apr 7, 2026
Split Type	Reverse
Split Ratio	0.0333333

Scores

TelyRx Holdings has an Altman Z-Score of -1.93 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.93
Piotroski F-Score	1